系统性硬化症进展性间质性肺病患者的循环单核细胞优先表达M2表型标志物
OBJECTIVE: To characterise phenotype and functional profibrotic M2 markers in circulating monocytes and cultured monocyte-derived macrophages (MDMs) from systemic sclerosis (SSc) patients (pts) with progressive interstitial lung disease (ILD) (prog-ILD), non-progressive ILD (no-p…
要点
- prog-ILD SSc患者循环单核细胞中TLR4+CD204+CD206+CD163+比例显著高于no-prog-ILD和no-ILD患者。
- prog-ILD SSc患者MDMs的TGFβ1基因表达和蛋白合成显著高于no-prog-ILD患者。
- prog-ILD SSc患者MDMs的MerTK、CD206、IL4和CCL18蛋白合成显著高于no-prog-ILD患者。
核心结论
- prog-ILD SSc患者的循环单核细胞来源巨噬细胞显示促纤维化生物标志物和介质表达显著增加,表明相较于非进展性和无ILD的SSc患者存在增强的纤维化表型。
研究设计与样本
- 对29例SSc患者的单核细胞来源巨噬细胞(MDMs)采用定量实时PCR和Western blotting分析基因表达和蛋白合成,并通过ELISA检测培养上清中IL6、IL4、CCL2/MCP1和CCL18。
主要发现
- prog-ILD SSc患者TLR4+CD204+CD206+CD163+单核细胞百分比高于no-prog-ILD患者,且显著高于no-ILD SSc患者。
- prog-ILD SSc患者MDMs的TGFβ1基因表达和蛋白合成、MerTK和CD206蛋白合成、IL4和CCL18蛋白合成均显著高于no-prog-ILD SSc患者。
- prog-ILD SSc患者MDMs中TGFβ1、TLR4、CD206、CD163、ARG1、MerTK和IL6的基因表达和蛋白合成显著高于no-ILD SSc患者。
临床怎么用
- 循环单核细胞M2表型标志物(如CD204、CD206、CD163)及MDMs促纤维化介质(TGFβ1、MerTK、ARG1、CCL18等)可能有助于识别SSc患者中ILD进展风险较高的个体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterise phenotype and functional profibrotic M2 markers in circulating monocytes and cultured monocyte-derived macrophages (MDMs) from systemic sclerosis (SSc) patients (pts) with progressive interstitial lung disease (ILD) (prog-ILD), non-progressive ILD (no-prog-ILD) and without ILD (no-ILD). METHODS: Fifty-five SSc pts and 20 age-matched healthy controls were evaluated. In 36 SSc pts, circulating monocytes expressing toll-like receptor-4 (TLR4, M1 marker) and M2 phenotype markers (CD204, CD206, CD163) were detected by flow cytometry. Moreover, MDMs of 29 SSc pts were analysed by quantitative real-time PCR and Western blotting for gene expression and protein synthesis with regard to the production of profibrotic mediators: transforming growth factor-ß1 (TGFß1), Mer tyrosine kinase receptor (MerTK) and arginase-1 (ARG1). Interleukin-6 and 4 (IL6, IL4), as well as C-C motif chemokine ligand 2 and 18 (CCL2/MCP1 and CCL18) from culture medium, were evaluated by enzyme-linked immunosorbent assay (ELISA). RESULTS: Prog-ILD SSc pts showed a higher percentage of TLR4+CD204+CD206+CD163+ monocytes versus no-prog-ILD, and significantly higher compared with no-ILD SSc pts.Interestingly, MDMs from prog-ILD SSc pts showed a significantly higher gene expression and protein synthesis of TGFβ1, and a significantly higher protein synthesis of MerTK, CD206, IL4 and CCL18 compared with no-prog-ILD SSc pts. Finally, gene expression and protein synthesis of TGFβ1, TLR4, CD206, CD163, ARG1, MerTK and IL6 were significantly increased in prog-ILD SSc versus no-ILD SSc MDMs. CONCLUSIONS: Cultured MDMs from circulating monocytes in SSc pts with prog-ILD show markedly increased profibrotic biomarkers and mediator expression, indicating an enhanced fibrotic phenotype compared to non-prog and no-ILD SSc pts.
引用
- Smith V, Soldano S, Campitiello R, et al. Circulating monocytes from systemic sclerosis patients with progressive interstitial lung disease preferentially express M2 phenotype markers: in vitro and ex vivo study. RMD Open. 2025. PMID: 41381212. doi:10.1136/rmdopen-2025-006135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。